Key result
England's Health Technology Assessment Programme operates independently to distinguish scientific assessment from policy appraisal.
Why the study?
The Health Technology Assessment Programme in England addresses the need for research on technologies important to the NHS, distinguishing assessment from appraisal roles.
Describes the Health Technology Assessment Programme in England, highlighting its needs-led approach and the distinction between scientific assessment and policy appraisal.
May guide needs-based HTA prioritization in cardiology; leaves open generalizability beyond England.
The Health Technology Assessment (HTA) Programme in England is a government-funded but independent research program. It is "needs-led", identifying technologies of most importance to the National Health Service and commissioning research to provide answers on these technologies useful to policymakers, clinicians and patients. It is "science-added", refining problems to researchable questions and working with researchers to ensure that the question is addressed, and disseminating the findings to key audiences. There is a clear distinction in England between assessment (a scientific process and the role of the HTA Programme) and appraisal (the role of policymakers, like the National Institute for Health and Clinical Excellence). There are many features common to HTA in Australia and England, but also differences, as HTA in each country has to adapt to its own environment.
No takes yet. Share an insight, caveat, or question.
Tom Walley (2007) reported a review. Health Technology Assessment was evaluated. The Health Technology Assessment Programme in England operates as an independent, needs-led research program that clearly distinguishes scientific assessment from policy appraisal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: